Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Ramaswami
Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Mitoxantrone-Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma
Turkish Journal of Medical Sciences
Medicine
Autologous Stem Cell Transplantation (ASCT) Is Effective Therapy for Older Patients With Non-Hodgkin's Lymphoma (NHL)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Autologous Stem Cell Transplantation Outcomes in Elderly Patients With B Cell Non-Hodgkin Lymphoma
British Journal of Haematology
Hematology
PSY5 Comparing Brentuximab Vedotin Overall Survival Data to Standard of Care in Patients With Relapsed/Refractory Hodgkin Lymphoma (HL) Post-Autologous Stem Cell Transplant (ASCT)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation in the Rituximab Era
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Significance of Salvage Autologous Stem Cell Transplantation (ASCT) for Patients With Multiple Myeloma Relapsing After Up-Front ASCT
Journal of Hematopoietic Cell Transplantation
Outcomes of Patients With Relapsed/Refractory Hodgkin Lymphoma Progressing After Autologous Stem Cell Transplant in the Current Era of Novel Therapeutics: A Retrospective Analysis
American Journal of Hematology
Hematology
Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology